A genetic link between risk for Alzheimer's disease and severe COVID-19 outcomes via the OAS1 gene
Open accessThe DOI matches its Crossref record; 124 of the 124 references it cites were found in a registry or an index.
Abstract
Recently, we reported oligoadenylate synthetase 1 (OAS1) contributed to the risk of Alzheimer’s disease, by its enrichment in transcriptional networks expressed by microglia. However, the function of OAS1 within microglia was not known. Using genotyping from 1313 individuals with sporadic Alzheimer’s disease and 1234 control individuals, we confirm the OAS1 variant, rs1131454, is associated with increased risk for Alzheimer’s disease. The same OAS1 locus has been recently associated with severe coronavirus disease 2019 (COVID-19) outcomes, linking risk for both diseases. The single nucleotide polymorphisms rs1131454(A) and rs4766676(T) are associated with Alzheimer’s disease, and rs10735079(A) and rs6489867(T) are associated with severe COVID-19, where the risk alleles are linked with decreased OAS1 expression. Analysing single-cell RNA-sequencing data of myeloid cells from Alzheimer’s disease and COVID-19 patients, we identify co-expression networks containing interferon (IFN)-responsive genes, including OAS1, which are significantly upregulated with age and both diseases. In human induced pluripotent stem cell-derived microglia with lowered OAS1 expression, we show exaggerated production of TNF-α with IFN-γ stimulation, indicating OAS1 is required to limit the pro-inflammatory response of myeloid cells. Collectively, our data support a link between genetic risk for Alzheimer’s disease and susceptibility to critical illness with COVID-19 centred on OAS1, a finding with potential implications for future treatments of Alzheimer’s disease and COVID-19, and development of biomarkers to track disease progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“From a genetic perspective, some genes such as APOE4 and oligoadenylate synthetase 1 (OAS1) play important roles in susceptibility to both COVID-19 and AD.”
From Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies. (2024) · cites this paper as [606]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“and linked with a pro-inflammatory response via STAT/NF-kappaB in microglia/macrophages when experimentally downregulated [60].”
From Genetic drivers of progression in Alzheimer’s disease are distinct from disease risk (2026) · cites this paper as [60]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Some variants in the interferon-responsive gene OAS1 may lower its expression and potentially increase the likelihood of AD and severe COVID-19, through excessive release of pro-inflammatory signals in myeloid cells such as microglia and macrophages, further leading to cell death.606”
From Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies. (2024) · cites this paper as [606]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106 · cited 1×
“Data were normalized using DeSeq2’s estimatesizefactors function and transformed by log2(normalized counts + 1).(71) Genes with an average detection level 51.”
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
limma powers differential expression analyses for RNA-sequencing and microarray studies
Ritchie, M. E., Phipson, B., Wu, D., Hu, Y., Law, C. W., Shi, W., & Smyth, G. K. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv007 · Cited by 40,458 · cited 1×
“dataset was removed using Limma’s RemoveBatchEffect function, preserving the effect of age using the mod argument.(72) Batch information was not available for data from Friedman et al.”
MethodPLINK: a tool set for whole-genome association and population-based linkage analyses.
Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M. A. R., Bender, D., Maller, J., Sklar, P., de Bakker, P. I. W., Daly, M. J., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/519795 · Cited by 34,089 · cited 2×
“regression correcting for the covariates with the statistical analysis program PLINK.(59) SNPs in the locus containing OAS1 associated with Alzheimer’s disease,(12,60) and COVID-19,(32) were illustrated with LocusZoom.”
MethodWGCNA: an R package for weighted correlation network analysis
Langfelder, P., & Horvath, S. (2008) · BMC Bioinformatics · doi:10.1186/1471-2105-9-559 · Cited by 27,252
Vandesompele, J., De Preter, K., Pattyn, F., Poppe, B., Van Roy, N., De Paepe, A., & Speleman, F. (2002) · Genome Biology · doi:10.1186/gb-2002-3-7-research0034 · Cited by 20,038 · cited 1×
“Gene expression analyses were performed by following the GeNorm method.(79,80)”
MethodA global reference for human genetic variation
The 1000 Genomes Project Consortium, authors, C., Auton, A., Abecasis, G. R., Steering committee, Altshuler, D. M., Durbin, R. M., Abecasis, G. R., Bentley, D. R., Chakravarti, A., et al. (2015) · Nature · doi:10.1038/nature15393 · Cited by 18,247
Comprehensive Integration of Single-Cell Data
Stuart, T., Butler, A., Hoffman, P., Hafemeister, C., Papalexi, E., Mauck, W. M., Hao, Y., Stoeckius, M., Smibert, P., & Satija, R. (2019) · Cell · doi:10.1016/j.cell.2019.05.031 · Cited by 15,453
Neurotoxic reactive astrocytes are induced by activated microglia
Liddelow, S. A., Guttenplan, K. A., Clarke, L. E., Bennett, F. C., Bohlen, C. J., Schirmer, L., Bennett, M. L., Münch, A. E., Chung, W.-S., Peterson, T. C., et al. (2017) · Nature · doi:10.1038/nature21029 · Cited by 7,971 · cited 1×
“TNF-a with C1Q complement (which also shows elevated expression in our human iPSC-derived microglia system in response to OAS1 knockdown), has been shown to induce the activation of reactive astrocytes, which contribute to synaptic damage, phagocytosis, and death of neurons and oligodendrocytes.(105) Previously, we an…”
BackgroundTrapnell, C., Cacchiarelli, D., Grimsby, J., Pokharel, P., Li, S., Morse, M., Lennon, N. J., Livak, K. J., Mikkelsen, T. S., & Rinn, J. L. (2014) · Nature Biotechnology · doi:10.1038/nbt.2859 · Cited by 7,314
Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China
Mao, L., Jin, H., Wang, M., Hu, Y., Chen, S., He, Q., Chang, J., Hong, C., Zhou, Y., Wang, D., et al. (2020) · JAMA Neurology · doi:10.1001/jamaneurol.2020.1127 · Cited by 7,166 · cited 1×
“Coupling these findings with the high incidence of neurological problems in people showing a severe COVID-19 response, 37– 40 emphasizes the urgency with which we need to understand the mechanisms underlying the changes to cytokine signalling regulated by interferon signalling, particularly to…”
BackgroundA Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease
Keren-Shaul, H., Spinrad, A., Weiner, A., Matcovitch-Natan, O., Dvir-Szternfeld, R., Ulland, T. K., David, E., Baruch, K., Lara-Astaiso, D., Toth, B., et al. (2017) · Cell · doi:10.1016/j.cell.2017.05.018 · Cited by 5,493 · cited 2×
“ease progression, particularly in the identification of disease-associated microglia (DAM) or amyloid-responsive microglia (ARM).(8,9)”
BackgroundReversed graph embedding resolves complex single-cell trajectories
Qiu, X., Mao, Q., Tang, Y., Wang, L., Chawla, R., Pliner, H. A., & Trapnell, C. (2017) · Nature Methods · doi:10.1038/nmeth.4402 · Cited by 5,070 · cited 1×
“To infer pseudotime trajectories of microglial activation, we followed the standard workflow of the Monocle 2 R package, 76,77 to calculate single-cell trajectories by ordering cells by their expression of the 1000 genes most significantly differentially expressed between cell clusters (ranked by…”
MethodThe Genotype-Tissue Expression (GTEx) pilot analysis: Multitissue gene regulation in humans
The GTEx Consortium, Ardlie, K. G., Deluca, D. S., Segrè, A. V., Sullivan, T. J., Young, T. R., Gelfand, E. T., Trowbridge, C. A., Maller, J. B., Tukiainen, T., et al. (2015) · Science · doi:10.1126/science.1262110 · Cited by 5,062 · cited 1×
“pression of OAS1 at the four SNPs of interest (rs1131454 and rs4766676 associated with Alzheimer’s disease; rs10735079 and rs6489867 associated with critical illness with COVID-19), were investigated by mining data for whole blood, frontal cortex (BA9), and lung from the Genotype-Tissue Expression (GTEx) Project via t…”
MethodDysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
Qin, C., Zhou, L., Hu, Z., Zhang, S., Yang, S., Tao, Y., Xie, C., Ma, K., Shang, K., Wang, W., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa248 · Cited by 4,775
Clinical and immunological features of severe and moderate coronavirus disease 2019
Chen, G., Wu, D., Guo, W., Cao, Y., Huang, D., Wang, H., Wang, T., Zhang, X., Chen, H., Yu, H., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci137244 · Cited by 4,750
Hafemeister, C., & Satija, R. (2019) · Genome Biology · doi:10.1186/s13059-019-1874-1 · Cited by 4,479
Meta-Analysis of 74,046 Individuals Identifies 11 New Susceptibility Loci for Alzheimer’s Disease
(EADI), E. A. D. I., Lambert, J.-C., (GERAD), G. A. E. R. I. A. D., Alzheimer's Disease Genetic Consortium (ADGC), (CHARGE), C. F. H. A. A. R. I. G. E., Ibrahim-Verbaas, C. A., Harold, D., Naj, A. C., Sims, R., Bellenguez, C., et al. (2013) · Nature Genetics · doi:10.1038/ng.2802 · Cited by 4,336
Self-citationComplement and microglia mediate early synapse loss in Alzheimer mouse models
Hong, S., Beja-Glasser, V. F., Nfonoyim, B. M., Frouin, A., Li, S., Ramakrishnan, S., Merry, K. M., Shi, Q., Rosenthal, A., Barres, B. A., et al. (2016) · Science · doi:10.1126/science.aad8373 · Cited by 3,343 · cited 2×
“These DAM or ARM cells are thought to regulate complement-dependent phagocytosis of synapses, which may be dependent on phospholipid signals presented on damaged cell membranes.(1,6,10,90,91) Emerging data also indicate that other subpopulations of microglia play a significant role in Alzheimer’s disease and ageing, p…”
BackgroundMethodImpaired type I interferon activity and inflammatory responses in severe COVID-19 patients
Hadjadj, J., Yatim, N., Barnabei, L., Corneau, A., Boussier, J., Smith, N., Péré, H., Charbit, B., Bondet, V., Chenevier-Gobeaux, C., et al. (2020) · Science · doi:10.1126/science.abc6027 · Cited by 2,984
Krasemann, S., Madore, C., Cialic, R., Baufeld, C., Calcagno, N., El Fatimy, R., Beckers, L., O’Loughlin, E., Xu, Y., Fanek, Z., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.08.008 · Cited by 2,979 · cited 1×
“ly involved in the same signalling pathway or functioning in the same subpopulation of microglia to control their activation to a socalled DAM or ARM state.(8,9,88,89) These DAM or ARM cells are thought to regulate complement-dependent phagocytosis of synapses, which may be dependent on phospholipid signals presented…”
BackgroundAlzheimer Disease Genetics Consortium (ADGC), Kunkle, B. W., The European Alzheimer’s Disease Initiative (EADI), Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium (CHARGE), Genetic and Environmental Risk in AD/Defining Genetic, P. A. E. R. F. A. D. C. (., Grenier-Boley, B., Sims, R., Bis, J. C., Damotte, V., Naj, A. C., et al. (2019) · Nature Genetics · doi:10.1038/s41588-019-0358-2 · Cited by 2,946
LocusZoom: regional visualization of genome-wide association scan results
Pruim, R. J., Welch, R. P., Sanna, S., Teslovich, T. M., Chines, P. S., Gliedt, T. P., Boehnke, M., Abecasis, G. R., & Willer, C. J. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq419 · Cited by 2,707
Autoantibodies against type I IFNs in patients with life-threatening COVID-19
Bastard, P., Rosen, L. B., Zhang, Q., Michailidis, E., Hoffmann, H.-H., Zhang, Y., Dorgham, K., Philippot, Q., Rosain, J., Béziat, V., et al. (2020) · Science · doi:10.1126/science.abd4585 · Cited by 2,662
Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19
Liao, M., Liu, Y., Yuan, J., Wen, Y., Xu, G., Zhao, J., Cheng, L., Li, J., Wang, X., Wang, F., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0901-9 · Cited by 2,614 · cited 2×
“(C) Genetic network plot of an interferon-response-associated module detected in macrophages isolated from the bronchoalveolar fluid of patients with severe/critical and moderate COVID-19, alongside healthy individuals analysed by scRNA-seq.(66) This module shows a significant overlap with the interferon-response modu…”
BackgroundMethodSingle-cell transcriptomic analysis of Alzheimer’s disease
Mathys, H., Davila-Velderrain, J., Peng, Z., Gao, F., Mohammadi, S., Young, J. Z., Menon, M., He, L., Abdurrob, F., Jiang, X., et al. (2019) · Nature · doi:10.1038/s41586-019-1195-2 · Cited by 2,568
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19
Zhang, Q., Bastard, P., Liu, Z., Le Pen, J., Moncada-Velez, M., Chen, J., Ogishi, M., Sabli, I. K. D., Hodeib, S., Korol, C., et al. (2020) · Science · doi:10.1126/science.abd4570 · Cited by 2,229 · cited 1×
“with life-threatening COVID-19 pneumonia in an independent study.(34) Indeed, neutralizing autoantibodies against interferons have been identified in individuals with life-threatening COVID-19, where these antibodies dampen the interferon response.”
BackgroundInterferon-inducible antiviral effectors
Sadler, A. J., & Williams, B. R. G. (2008) · Nature Reviews Immunology · doi:10.1038/nri2314 · Cited by 2,160 · cited 2×
“lar effectors to inhibit transcription of viral nucleic acids, digest viral RNA, block translation and modify protein function.(15) The microglial interferon response has recently been implicated in neuroinflammation and synapse loss in Alzheimer’s disease; however, it is unclear how interferon signalling and antivira…”
BackgroundMachiela, M. J., & Chanock, S. J. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btv402 · Cited by 2,069 · cited 1×
“…frequencies and LD between these SNPs were investigated using the 1000Genomes Phase 3 data (European populations, CEU and GBR), 62 and LDlink, 63,64 where the LD between SNPs was calculated with the LDpair tool (available at https://ldlink.nci.nih.gov/?tab=ldpair using data from European…”
MethodKarki, R., Sharma, B. R., Tuladhar, S., Williams, E. P., Zalduondo, L., Samir, P., Zheng, M., Sundaram, B., Banoth, B., Malireddi, R. K. S., et al. (2021) · Cell · doi:10.1016/j.cell.2020.11.025 · Cited by 1,734
NLRP3 inflammasome activation drives tau pathology
Ising, C., Venegas, C., Zhang, S., Scheiblich, H., Schmidt, S. V., Vieira-Saecker, A., Schwartz, S., Albasset, S., McManus, R. M., Tejera, D., et al. (2019) · Nature · doi:10.1038/s41586-019-1769-z · Cited by 1,487
DNA sensing by the cGAS–STING pathway in health and disease
Motwani, M., Pesiridis, S., & Fitzgerald, K. A. (2019) · Nature Reviews Genetics · doi:10.1038/s41576-019-0151-1 · Cited by 1,467 · cited 2×
“cGAS-STING pathway), which respond to not only pathogenderived nucleic acids, but also mitochondrial and genomic nucleic acids derived from stressed, senescent or dying cells in the CNS.(22,23) While type I interferon signalling was reported to be associated with microglial activation patterns and Alzheimer’s disease,…”
BackgroundGenetic mechanisms of critical illness in COVID-19
The GenOMICC Investigators, Pairo-Castineira, E., The ISARIC4C Investigators, Initiative, T. C.-1. H. G., 23andMe Investigators, BRACOVID Investigators, Gen-COVID Investigators, Clohisey, S., Klaric, L., Bretherick, A. D., et al. (2021) · Nature · doi:10.1038/s41586-020-03065-y · Cited by 1,365
Neuropathology of patients with COVID-19 in Germany: a post-mortem case series
Matschke, J., Lütgehetmann, M., Hagel, C., Sperhake, J. P., Schröder, A. S., Edler, C., Mushumba, H., Fitzek, A., Allweiss, L., Dandri, M., et al. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(20)30308-2 · Cited by 1,300 · cited 1×
“There is accumulating evidence that these brain structures and cells are infected with SARS-CoV-2 and are altering the cytokine profile of the brain.(46,47) Elevated levels of proinflammatory cytokines including tumour necrosis factor-a (TNFa), interleukin (IL)-1 and IL-6 in patients with severe COVID-19,”
BackgroundThe emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings
Paterson, R. W., Brown, R. L., Benjamin, L., Nortley, R., Wiethoff, S., Bharucha, T., Jayaseelan, D. L., Kumar, G., Raftopoulos, R. E., Zambreanu, L., et al. (2020) · Brain · doi:10.1093/brain/awaa240 · Cited by 1,124 · cited 1×
“Coupling these findings with the high incidence of neurological problems in people showing a severe COVID-19 response, 37– 40 emphasizes the urgency with which we need to understand the mechanisms underlying the changes to cytokine signalling regulated by interferon signalling, particularly to…”
BackgroundKolberg, L., Raudvere, U., Kuzmin, I., Vilo, J., & Peterson, H. (2020) · F1000Research · doi:10.12688/f1000research.24956.2 · Cited by 1,098
ARUK Consortium, Sims, R., GERAD/PERADES, C., van der Lee, S. J., Naj, A. C., Bellenguez, C., Badarinarayan, N., Jakobsdottir, J., Kunkle, B. W., Boland, A., et al. (2017) · Nature Genetics · doi:10.1038/ng.3916 · Cited by 1,012 · cited 1×
“7 Integrating genetic variants with RNA-sequencing (RNA-seq) and single-cell RNA-sequencing (scRNA-seq) approaches has begun to provide important new insights into the heterogeneous microglial activity changes in Alzheimer’s disease progression, particularly in the identification of…”
BackgroundMapping the human genetic architecture of COVID-19
Initiative, C.-1. H. G., InitiativeLeadership, C.-1. H. G., Niemi, M. E. K., Karjalainen, J., Liao, R. G., Neale, B. M., Daly, M., Ganna, A., Writing group, Writing group leaders, et al. (2021) · Nature · doi:10.1038/s41586-021-03767-x · Cited by 983
Central nervous system involvement by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)
Paniz‐Mondolfi, A., Bryce, C., Grimes, Z., Gordon, R. E., Reidy, J., Lednicky, J., Sordillo, E. M., & Fowkes, M. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25915 · Cited by 975
Sala Frigerio, C., Wolfs, L., Fattorelli, N., Thrupp, N., Voytyuk, I., Schmidt, I., Mancuso, R., Chen, W.-T., Woodbury, M. E., Srivastava, G., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.03.099 · Cited by 926 · cited 7×
“ly involved in the same signalling pathway or functioning in the same subpopulation of microglia to control their activation to a socalled DAM or ARM state.(8,9,88,89) These DAM or ARM cells are thought to regulate complement-dependent phagocytosis of synapses, which may be dependent on phospholipid signals presented…”
BackgroundMethodInfluentialImpact of Genetic Polymorphisms on Human Immune Cell Gene Expression
Schmiedel, B. J., Singh, D., Madrigal, A., Valdovino-Gonzalez, A. G., White, B. M., Zapardiel-Gonzalo, J., Ha, B., Altay, G., Greenbaum, J. A., McVicker, G., et al. (2018) · Cell · doi:10.1016/j.cell.2018.10.022 · Cited by 867 · cited 1×
“OAS1 is expressed by multiple cell types in the myeloid lineage including monocytes, macrophages, and microglia, as well as natural killer cell lymphocytes.(33,81,82,94) Here, we show that rs1131454 within OAS1 is associated with Alzheimer’s disease, and previously we showed that this locus acts as an eQTL regulating…”
BackgroundLee, J. S., Park, S., Jeong, H. W., Ahn, J. Y., Choi, S. J., Lee, H., Choi, B., Nam, S. K., Sa, M., Kwon, J.-S., et al. (2020) · Science Immunology · doi:10.1126/sciimmunol.abd1554 · Cited by 825 · cited 1×
“46,47 Elevated levels of pro-inflammatory cytokines including tumour necrosis factor-a (TNF-a ), interleukin (IL)-1 and IL-6 in patients with severe COVID-19, 48–56 trigger an inflammatory cascade leading to cell death.”
BackgroundYuan, P., Condello, C., Keene, C. D., Wang, Y., Bird, T. D., Paul, S. M., Luo, W., Colonna, M., Baddeley, D., & Grutzendler, J. (2016) · Neuron · doi:10.1016/j.neuron.2016.05.003 · Cited by 817
Transcriptomic analysis of purified human cortical microglia reveals age-associated changes
Galatro, T. F., Holtman, I. R., Lerario, A. M., Vainchtein, I. D., Brouwer, N., Sola, P. R., Veras, M. M., Pereira, T. F., Leite, R. E. P., Möller, T., et al. (2017) · Nature Neuroscience · doi:10.1038/nn.4597 · Cited by 741
Neurologic manifestations in hospitalized patients with COVID-19: The ALBACOVID registry
Romero-Sánchez, C. M., Díaz-Maroto, I., Fernández-Díaz, E., Sánchez-Larsen, Á., Layos-Romero, A., García-García, J., González, E., Redondo-Peñas, I., Perona-Moratalla, A. B., Del Valle-Pérez, J. A., et al. (2020) · Neurology · doi:10.1212/wnl.0000000000009937 · Cited by 737
Single cell RNA sequencing of human microglia uncovers a subset associated with Alzheimer’s disease
Olah, M., Menon, V., Habib, N., Taga, M. F., Ma, Y., Yung, C. J., Cimpean, M., Khairallah, A., Coronas-Samano, G., Sankowski, R., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19737-2 · Cited by 722 · cited 3×
“The interferon-responsive genes seen in aged mice, and mice with amyloid plaques, were also expressed in a specific sub-population of microglia that are present in brains from people with Alzheimer’s disease.(19) The genetic network we identified in human brains with Alzheimer’s disease containing OAS1 and other inter…”
BackgroundMethodSilverman, R. H. (2007) · Journal of Virology · doi:10.1128/jvi.01471-07 · Cited by 671 · cited 4×
“OAS1 is an oli-goadenylate synthetase enzyme that binds dsRNA and changes conformation to generate oligoadenylates and activate RNase L to digest RNA.”
BackgroundInfluentialFriedman, B. A., Srinivasan, K., Ayalon, G., Meilandt, W. J., Lin, H., Huntley, M. A., Cao, Y., Lee, S.-H., Haddick, P. C. G., Ngu, H., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2017.12.066 · Cited by 662 · cited 4×
“normal ageing, and increases even further in response to amyloid pathology.(9,13) However, the mechanisms of action of IRM in both”
BackgroundMethodInfluentialNeurologic alterations due to respiratory virus infections
Bohmwald, K., Gálvez, N. M. S., Ríos, M., & Kalergis, A. M. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00386 · Cited by 636
Dysregulation of brain and choroid plexus cell types in severe COVID-19
Yang, A. C., Kern, F., Losada, P. M., Agam, M. R., Maat, C. A., Schmartz, G. P., Fehlmann, T., Stein, J. A., Schaum, N., Lee, D. P., et al. (2021) · Nature · doi:10.1038/s41586-021-03710-0 · Cited by 620 · cited 1×
“There is accumulating evidence that these brain structures and cells are infected with SARS-CoV-2 and are altering the cytokine profile of the brain.(46,47) Elevated levels of proinflammatory cytokines including tumour necrosis factor-a (TNFa), interleukin (IL)-1 and IL-6 in patients with severe COVID-19,”
BackgroundThe Spatial and Cell-Type Distribution of SARS-CoV-2 Receptor ACE2 in the Human and Mouse Brains
Chen, R., Wang, K., Yu, J., Howard, D., French, L., Chen, Z., Wen, C., & Xu, Z. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2020.573095 · Cited by 570
Type I interferon response drives neuroinflammation and synapse loss in Alzheimer disease
Roy, E. R., Wang, B., Wan, Y.-W., Chiu, G., Cole, A., Yin, Z., Propson, N. E., Xu, Y., Jankowsky, J. L., Liu, Z., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci133737 · Cited by 563 · cited 1×
“15 20 It has been proposed that nucleic acid-containing amyloid fibrils induce the expression of inter-feron-stimulated genes in Alzheimer’s disease-associated mouse models, promoting the upregulation of pro-inflammatory markers and complement cascade-dependent synaptic elimination.”
BackgroundLate onset Alzheimer’s disease genetics implicates microglial pathways in disease risk
Efthymiou, A. G., & Goate, A. M. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0184-x · Cited by 562
Loss of TREM2 function increases amyloid seeding but reduces plaque-associated ApoE
Parhizkar, S., Arzberger, T., Brendel, M., Kleinberger, G., Deussing, M., Focke, C., Nuscher, B., Xiong, M., Ghasemigharagoz, A., Katzmarski, N., et al. (2019) · Nature Neuroscience · doi:10.1038/s41593-018-0296-9 · Cited by 555
Local externalization of phosphatidylserine mediates developmental synaptic pruning by microglia
Scott‐Hewitt, N., Perrucci, F., Morini, R., Erreni, M., Mahoney, M., Witkowska, A., Carey, A., Faggiani, E., Schuetz, L. T., Mason, S., et al. (2020) · The EMBO Journal · doi:10.15252/embj.2020105380 · Cited by 430 · cited 1×
“These DAM or ARM cells are thought to regulate complement-dependent phagocytosis of synapses, which may be dependent on phospholipid signals presented on damaged cell membranes.(1,6,10,90,91) Emerging data also indicate that other subpopulations of microglia play a significant role in Alzheimer’s disease and ageing, p…”
BackgroundMyers, T. A., Chanock, S. J., & Machiela, M. J. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00157 · Cited by 429 · cited 2×
“Allele frequency at these SNPs was investigated using the 1000Genomes Phase 3 data (CEU and GBR populations),(62) and LDlink.(63,64)”
MethodLong-Term Respiratory and Neurological Sequelae of COVID-19
Wang, F., Kream, R. M., & Stefano, G. B. (2020) · Medical Science Monitor · doi:10.12659/msm.928996 · Cited by 427 · cited 12×
“The equivalent co-expression network was also expressed in microglia from humans with Alzheimer’s disease and mild cognitive impairment, and in bronchoalveolar lavage fluid (BALF) macrophages, where the expression of this network is elevated with severe COVID-19.”
BackgroundInfluentialThe type I interferon response in COVID-19: implications for treatment
Lee, J. S., & Shin, E.-C. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-00429-3 · Cited by 421
The age factor in Alzheimer’s disease
Guerreiro, R., & Bras, J. (2015) · Genome Medicine · doi:10.1186/s13073-015-0232-5 · Cited by 415 · cited 12×
“The equivalent co-expression network was also expressed in microglia from humans with Alzheimer’s disease and mild cognitive impairment, and in bronchoalveolar lavage fluid (BALF) macrophages, where the expression of this network is elevated with severe COVID-19.”
BackgroundInfluentialFrequent neurocognitive deficits after recovery from mild COVID-19
Woo, M. S., Malsy, J., Pöttgen, J., Seddiq Zai, S., Ufer, F., Hadjilaou, A., Schmiedel, S., Addo, M. M., Gerloff, C., Heesen, C., et al. (2020) · Brain Communications · doi:10.1093/braincomms/fcaa205 · Cited by 394
TREM2 Acts Downstream of CD33 in Modulating Microglial Pathology in Alzheimer's Disease
Griciuc, A., Patel, S., Federico, A. N., Choi, S. H., Innes, B. J., Oram, M. K., Cereghetti, G., McGinty, D., Anselmo, A., Sadreyev, R. I., et al. (2019) · Neuron · doi:10.1016/j.neuron.2019.06.010 · Cited by 378 · cited 1×
“ly involved in the same signalling pathway or functioning in the same subpopulation of microglia to control their activation to a socalled DAM or ARM state.(8,9,88,89) These DAM or ARM cells are thought to regulate complement-dependent phagocytosis of synapses, which may be dependent on phospholipid signals presented…”
BackgroundLoss of TREM2 function increases amyloid seeding but reduces plaque-associated ApoE
Parhizkar, S., Arzberger, T., Brendel, M., Kleinberger, G., Deußing, M., Focke, C., Nuscher, B., Xiong, M., Ghasemigharagoz, A., Katzmarski, N., et al. (2019) · doi:10.7892/boris.125653 · Cited by 352
Anosmia in COVID-19: Underlying Mechanisms and Assessment of an Olfactory Route to Brain Infection
Butowt, R., & von Bartheld, C. S. (2021) · The Neuroscientist · doi:10.1177/1073858420956905 · Cited by 345 · cited 1×
“41–45 There is accumulating evidence that these brain structures and cells are infected with SARS-CoV-2 and are altering the cytokine profile of the brain.”
BackgroundHIPSCI Consortium, Alasoo, K., Rodrigues, J., Mukhopadhyay, S., Knights, A. J., Mann, A. L., Kundu, K., Hale, C., Dougan, G., & Gaffney, D. J. (2018) · Nature Genetics · doi:10.1038/s41588-018-0046-7 · Cited by 338 · cited 2×
“OAS1 is expressed by multiple cell types in the myeloid lineage including monocytes, macrophages, and microglia, as well as natural killer cell lymphocytes.(33,81,82,94)”
BackgroundTREM2 function impedes tau seeding in neuritic plaques
Leyns, C. E. G., Gratuze, M., Narasimhan, S., Jain, N., Koscal, L. J., Jiang, H., Manis, M., Colonna, M., Lee, V. M. Y., Ulrich, J. D., et al. (2019) · Nature Neuroscience · doi:10.1038/s41593-019-0433-0 · Cited by 332
Majoros, A., Platanitis, E., Kernbauer-Hölzl, E., Rosebrock, F., Müller, M., & Decker, T. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00029 · Cited by 325
Signaling by cGAS–STING in Neurodegeneration, Neuroinflammation, and Aging
Paul, B. D., Snyder, S. H., & Bohr, V. A. (2021) · Trends in Neurosciences · doi:10.1016/j.tins.2020.10.008 · Cited by 314 · cited 1×
“…only pathogen-derived nucleic acids, but also mitochondrial and genomic nucleic acids derived from stressed, senescent or dying cells in the CNS. 22,23 26 The molecular machinery that drives antiviral responses includes interferon receptors (IFNAR and IFNGR), tyrosine kinase 2 (TYK2),…”
BackgroundDavoudi-Monfared, E., Rahmani, H., Khalili, H., Hajiabdolbaghi, M., Salehi, M., Abbasian, L., Kazemzadeh, H., & Yekaninejad, M. S. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01061-20 · Cited by 306
The United Kingdom Brain Expression Consortium, Botía, J. A., Vandrovcova, J., Forabosco, P., Guelfi, S., D’Sa, K., Hardy, J., Lewis, C. M., Ryten, M., & Weale, M. E. (2017) · BMC Systems Biology · doi:10.1186/s12918-017-0420-6 · Cited by 289
Self-citationWang, N., Zhan, Y., Zhu, L., Hou, Z., Liu, F., Song, P., Qiu, F., Wang, X., Zou, X., Wan, D., et al. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.07.005 · Cited by 287
Activation of RNase L is dependent on OAS3 expression during infection with diverse human viruses
Li, Y., Banerjee, S., Wang, Y., Goldstein, S. A., Dong, B., Gaughan, C., Silverman, R. H., & Weiss, S. R. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1519657113 · Cited by 285 · cited 1×
“It has also been proposed that OAS1 may have RNase-independent roles.(29,30) OAS1 is expressed by multiple cell types in the myeloid lineage including monocytes, macrophages, and microglia, as well as natural killer cell lymphocytes.”
BackgroundHuman coronaviruses: Viral and cellular factors involved in neuroinvasiveness and neuropathogenesis
Desforges, M., Le Coupanec, A., Stodola, J. K., Meessen-Pinard, M., & Talbot, P. J. (2014) · Virus Research · doi:10.1016/j.virusres.2014.09.011 · Cited by 275
de Klein, N., Tsai, E. A., Vochteloo, M., Baird, D., Huang, Y., Chen, C.-Y., van Dam, S., Oelen, R., Deelen, P., Bakker, O. B., et al. (2023) · Nature Genetics · doi:10.1038/s41588-023-01300-6 · Cited by 272
A genomic region associated with protection against severe COVID-19 is inherited from Neandertals
Zeberg, H., & Pääbo, S. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2026309118 · Cited by 233 · cited 1×
“32,33,97 104 A recent study has identified a haplotype of (cid:4) 75kb centred around the OAS locus inherited from Neanderthals that is protective against COVID-19, 104 suggesting that there has been genetic selection at this locus during European history.”
BackgroundLiu, W., Taso, O., Wang, R., Bayram, S., Graham, A. C., Garcia-Reitboeck, P., Mallach, A., Andrews, W. D., Piers, T. M., Botia, J. A., et al. (2020) · Human Molecular Genetics · doi:10.1093/hmg/ddaa209 · Cited by 214
Self-citationKim-Hellmuth, S., Bechheim, M., Pütz, B., Mohammadi, P., Nédélec, Y., Giangreco, N., Becker, J., Kaiser, V., Fricker, N., Beier, E., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00366-1 · Cited by 203
Local apoptotic-like mechanisms underlie complement-mediated synaptic pruning
Györffy, B. A., Kun, J., Török, G., Bulyáki, É., Borhegyi, Z., Gulyássy, P., Kis, V., Szocsics, P., Micsonai, A., Matkó, J., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1722613115 · Cited by 187 · cited 1×
“1,6,10,90,91 19 We recently identified the interferon-responsive gene OAS1 as a putative risk gene for Alzheimer’s disease by combining transcriptional changes in the presence of amyloid plaques and gene-level variation from GWAS data.”
BackgroundXiang, X., Piers, T. M., Wefers, B., Zhu, K., Mallach, A., Brunner, B., Kleinberger, G., Song, W., Colonna, M., Herms, J., et al. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0280-6 · Cited by 170
Self-citationStructural basis for cytosolic double-stranded RNA surveillance by human oligoadenylate synthetase 1
Donovan, J., Dufner, M., & Korennykh, A. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1218528110 · Cited by 163 · cited 1×
“27,28 31 It has also been shown that OAS1 is involved in the regulation of cytokine expression.”
BackgroundA distinct innate immune signature marks progression from mild to severe COVID-19
Chevrier, S., Zurbuchen, Y., Cervia, C., Adamo, S., Raeber, M. E., de Souza, N., Sivapatham, S., Jacobs, A., Bächli, E., Rudiger, A., et al. (2020) · Cell Reports Medicine · doi:10.1016/j.xcrm.2020.100166 · Cited by 157 · cited 1×
“46,47 Elevated levels of pro-inflammatory cytokines including tumour necrosis factor-a (TNF-a ), interleukin (IL)-1 and IL-6 in patients with severe COVID-19, 48–56 trigger an inflammatory cascade leading to cell death.”
BackgroundBonnevie‐Nielsen, V., Field, L. L., Lu, S., Zheng, D., Li, M., Martensen, P. M., Nielsen, T. B., Beck‐Nielsen, H., Lau, Y., & Pociot, F. (2005) · The American Journal of Human Genetics · doi:10.1086/429391 · Cited by 155
COVID-19 and Alzheimer’s disease: how one crisis worsens the other
Xia, X., Wang, Y., & Zheng, J. (2021) · Translational Neurodegeneration · doi:10.1186/s40035-021-00237-2 · Cited by 152 · cited 1×
“is disrupted in Alzheimer’s disease, and it is common for individuals with hypertension and neurodegeneration to receive long-term treatment with ACE inhibitors and angiotensin II receptor blockers, which may ultimately increase ACE2 expression and so increase risk of infection with SARS-CoV-2 and disease severity.(57…”
BackgroundFibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models
Sebastian Monasor, L., Müller, S. A., Colombo, A. V., Tanrioever, G., König, J., Roth, S., Liesz, A., Berghofer, A., Piechotta, A., Prestel, M., et al. (2020) · eLife · doi:10.7554/elife.54083 · Cited by 147
Risk factors of severe cases with COVID-19: a meta-analysis
Ou, M., Zhu, J., Ji, P., Li, H., Zhong, Z., Li, B., Pang, J., Zhang, J., & Zheng, X. (2020) · Epidemiology and Infection · doi:10.1017/s095026882000179x · Cited by 146 · cited 2×
“86,87 To investigate how the interferon-response microglial network containing OAS1 from Alzheimer’s disease brains was related to myeloid cell activation during COVID-19, we performed a similar analysis in BALF macrophages from COVID-19 patients with modest or severe disease, and healthy controls.”
BackgroundMethodDissecting the genetic relationship between cardiovascular risk factors and Alzheimer’s disease
Broce, I. J., Tan, C. H., Fan, C. C., Jansen, I., Savage, J. E., Witoelar, A., Wen, N., Hess, C. P., Dillon, W. P., Glastonbury, C. M., et al. (2019) · Acta Neuropathologica · doi:10.1007/s00401-018-1928-6 · Cited by 140 · cited 1×
“Also in the same locus is OAS2, which was independently shown to be associated with Alzheimer’s disease.(95,96) Recent work has identified other SNPs close to this locus associated with severe”
BackgroundA unifying hypothesis for Alzheimer's disease: from plaques to neurodegeneration
Edwards, F. A. (2019) · Trends in Neurosciences · doi:10.1016/j.tins.2019.03.003 · Cited by 140 · cited 2×
“These DAM or ARM cells are thought to regulate complement-dependent phagocytosis of synapses, which may be dependent on phospholipid signals presented on damaged cell membranes.(1,6,10,90,91) Emerging data also indicate that other subpopulations of microglia play a significant role in Alzheimer’s disease and ageing, p…”
BackgroundType I/II Interferon Balance in the Regulation of Brain Physiology and Pathology
Deczkowska, A., Baruch, K., & Schwartz, M. (2016) · Trends in Immunology · doi:10.1016/j.it.2016.01.006 · Cited by 139
Zhou, J., Yu, W., Zhang, M., Tian, X., Li, Y., & Lü, Y. (2019) · Neurochemical Research · doi:10.1007/s11064-019-02748-x · Cited by 139
O’Neil, S. M., Witcher, K. G., McKim, D. B., & Godbout, J. P. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0636-8 · Cited by 138 · cited 3×
“log2 normalized expression of the 60 most central module genes in microglia isolated from aged versus young adult wild-type mice, and PSEN2/APP versus wild-type mice, and by applying Student’s ttest (the 60 most central module genes were ranked by module membership scores calculated by CoExpNets’ getMM function) per s…”
MethodInfluentialFoxO6 regulates memory consolidation and synaptic function
Salih, D. A. M., Rashid, A. J., Colas, D., de la Torre-Ubieta, L., Zhu, R. P., Morgan, A. A., Santo, E. E., Ucar, D., Devarajan, K., Cole, C. J., et al. (2012) · Genes & Development · doi:10.1101/gad.208926.112 · Cited by 137
Self-citationParenchymal accumulation of CD163+ macrophages/microglia in multiple sclerosis brains
Zhang, Z., Zhang, Z., Schittenhelm, J., Wu, Y., Meyermann, R., & Schluesener, H. J. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2011.06.006 · Cited by 136
RNA regulation of the antiviral protein 2′‐5′‐oligoadenylate synthetase
Schwartz, S. L., & Conn, G. L. (2019) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1534 · Cited by 134 · cited 4×
“OAS1 is an oli-goadenylate synthetase enzyme that binds dsRNA and changes conformation to generate oligoadenylates and activate RNase L to digest RNA.”
BackgroundInfluentialEllwanger, D. C., Wang, S., Brioschi, S., Shao, Z., Green, L., Case, R., Yoo, D., Weishuhn, D., Rathanaswami, P., Bradley, J., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2017742118 · Cited by 134 · cited 1×
“1,6,10,11 14 The number of IRM increases during normal ageing, and increases even further in response to amyloid pathology.”
BackgroundPey, P., Pearce, R. K., Kalaitzakis, M. E., Griffin, W. S. T., & Gentleman, S. M. (2014) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-2-21 · Cited by 128
Kristiansen, H., Scherer, C., McVean, M., Iadonato, S. P., Vends, S., Thavachelvam, K., Steffensen, T. B., Horan, K., Kuri, T., Weber, F., et al. (2010) · Journal of Virology · doi:10.1128/jvi.01003-10 · Cited by 119 · cited 1×
“It has also been proposed that OAS1 may have RNase-independent roles.(29,30) OAS1 is expressed by multiple cell types in the myeloid lineage including monocytes, macrophages, and microglia, as well as natural killer cell lymphocytes.”
BackgroundZheng, H., Liu, C.-C., Atagi, Y., Chen, X.-F., Jia, L., Yang, L., He, W., Zhang, X., Kang, S. S., Rosenberry, T. L., et al. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.03.004 · Cited by 110
Genetic variability in response to amyloid beta deposition influences Alzheimer’s disease risk
Salih, D. A., Bayram, S., Guelfi, S., Reynolds, R. H., Shoai, M., Ryten, M., Brenton, J. W., Zhang, D., Matarin, M., Botia, J. A., et al. (2019) · Brain Communications · doi:10.1093/braincomms/fcz022 · Cited by 110 · cited 10×
“59 SNPs in the locus containing OAS1 associated with Alzheimer’s disease, 12,60 and COVID-19, 32 were illustrated with LocusZoom.”
BackgroundMethodResultInfluentialSelf-citationMapping the human genetic architecture of COVID-19 by worldwide meta-analysis
Initiative, T. C.-1. H. G., & Ganna, A. (2021) · medRxiv · doi:10.1101/2021.03.10.21252820 · Cited by 103
He, J., Feng, D., de Vlas, S. J., Wang, H., Fontanet, A., Zhang, P., Plancoulaine, S., Tang, F., Zhan, L., Yang, H., et al. (2006) · BMC Infectious Diseases · doi:10.1186/1471-2334-6-106 · Cited by 101
Type-I interferon pathway in neuroinflammation and neurodegeneration: focus on Alzheimer’s disease
Taylor, J. M., Moore, Z., Minter, M. R., & Crack, P. J. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1745-4 · Cited by 97 · cited 1×
“…pathogen-derived nucleic acids, but also mitochondrial and genomic nucleic acids derived from stressed, senescent or dying cells in the CNS. 22,23 26 The molecular machinery that drives antiviral responses includes interferon receptors (IFNAR and IFNGR), tyrosine kinase 2 (TYK2), IFN-stimulated…”
BackgroundLaboratory biomarkers associated with COVID-19 severity and management
Keddie, S., Ziff, O. J., Chou, M., Taylor, R. L., Heslegrave, A., Garr, E., Lakdawala, N., Church, A. J., Ludwig, D., Manson, J. J., et al. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108614 · Cited by 84
Wood, E. R., Bledsoe, R., Chai, J., Daka, P., Deng, H., Ding, Y., Harris-Gurley, S., Kryn, L. H., Nartey, E., Nichols, J., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.653113 · Cited by 72
Schmiedel, B. J., Rocha, J., González-Colín, C., Bhattacharyya, S., Madrigal, A., Ottensmeier, C. H. H., Ay, F., Chandra, V., & Vijayanand, P. (2021) · Nature Communications · doi:10.1038/s41467-021-26888-3 · Cited by 70 · cited 4×
“cluster that modulate risk for both Alzheimer’s disease and severe COVID-19, via regulation of OAS1 expression.(12,32,33)”
InfluentialLee, W.-B., Choi, W. Y., Lee, D.-H., Shim, H., Kim-Ha, J., & Kim, Y.-J. (2019) · BMB Reports · doi:10.5483/bmbrep.2019.52.2.129 · Cited by 64 · cited 1×
“It has also been shown that OAS1 is involved in the regulation of cytokine expression.(31) We recently identified OAS1 as a putative new risk gene for Alzheimer’s disease, by integrating DNA sequence variation at the gene-level from human genome-wide association studies (GWAS) associated with Alzheimer’s disease, and…”
BackgroundBinding with Nucleic Acids or Glycosaminoglycans Converts Soluble Protein Oligomers to Amyloid
Di Domizio, J., Zhang, R., Stagg, L. J., Gagea, M., Zhuo, M., Ladbury, J. E., & Cao, W. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.238477 · Cited by 60 · cited 2×
“16,21 Another potential contributor to interferon signalling is the DNA-sensing receptor cyclic GMP–AMP synthase (cGAS) and its downstream mediator STimulator of INterferon Genes (STING; cGAS-STING pathway), which respond to not only pathogen-derived nucleic acids, but also mitochondrial and…”
BackgroundUnderstanding microglial diversity and implications for neuronal function in health and disease
De Schepper, S., Crowley, G., & Hong, S. (2021) · Developmental Neurobiology · doi:10.1002/dneu.22777 · Cited by 57
Multiple sclerosis: effect of beta interferon treatment on survival
Kingwell, E., Leray, E., Zhu, F., Petkau, J., Edan, G., Oger, J., & Tremlett, H. L. (2019) · Brain · doi:10.1093/brain/awz055 · Cited by 56
Divergent Neuroinflammatory Regulation of Microglial TREM Expression and Involvement of NF-κB
Owens, R., Grabert, K., Davies, C. L., Alfieri, A., Antel, J. P., Healy, L. M., & McColl, B. W. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00056 · Cited by 54
Human OAS1 activation is highly dependent on both RNA sequence and context of activating RNA motifs
Schwartz, S. L., Park, E. N., Vachon, V. K., Danzy, S., Lowen, A. C., & Conn, G. L. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa513 · Cited by 50 · cited 4×
“OAS1 is an oli-goadenylate synthetase enzyme that binds dsRNA and changes conformation to generate oligoadenylates and activate RNase L to digest RNA.”
BackgroundInfluentialType 1 diabetes and the OAS gene cluster: association with splicing polymorphism or haplotype?
Tessier, M.-C., Qu, H.-Q., Fréchette, R., Bacot, F., Grabs, R., Taback, S. P., Lawson, M. L., Kirsch, S. E., Hudson, T., & Polychronakos, C. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2005.035212 · Cited by 46 · cited 12×
“In addition to COVID-19, a SNP within OAS1 was also associated with type 1 diabetes and so OAS1 may integrate multiple risk factors that contribute to critical outcomes with COVID-19.(99)”
BackgroundInfluentialDvir-Szternfeld, R., Castellani, G., Arad, M., Cahalon, L., Colaiuta, S. P., Keren-Shaul, H., Croese, T., Burgaletto, C., Baruch, K., Ulland, T., et al. (2021) · Nature Aging · doi:10.1038/s43587-021-00149-w · Cited by 44
Defining functional variants associated with Alzheimer’s disease in the induced immune response
Harwood, J. C., Leonenko, G., Sims, R., Escott‐Price, V., Williams, J. H., & Holmans, P. (2021) · Brain Communications · doi:10.1093/braincomms/fcab083 · Cited by 36 · cited 1×
“In parallel, mining our transcriptome-wide association study (TWAS) analysis of Alzheimer’s disease, 85 provided further evidence that genetic variants associated with decreased expression of OAS1 are significantly more prevalent in patients with Alzheimer’s disease (Supplementary Table 3).”
BackgroundSelf-citationKunkle, B., Grenier-Boley, B., Sims, R., Bis, J., Naj, A., Boland, A., Vronskaya, M., van der Lee, S., Amlie-Wolf, A., Bellenguez, C., et al. (2018) · doi:10.1101/294629 · Cited by 35
Self-citationKlaassen, K., Stanković, B., Zukić, B., Kotur, N., Gašić, V., Pavlović, S., & Stojiljković, M. (2020) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2020.104498 · Cited by 32
Majd, R., Mayeli, M., & Rahmani, F. (2020) · Metabolic Brain Disease · doi:10.1007/s11011-020-00600-8 · Cited by 30
Heuer, S. E., Neuner, S. M., Hadad, N., O'Connell, K. M. S., Williams, R. W., Philip, V. M., Gaiteri, C., & Kaczorowski, C. C. (2020) · Learning & Memory · doi:10.1101/lm.051839.120 · Cited by 29
Genes, pathways and risk prediction in Alzheimer’s disease
Hardy, J., & Escott-Price, V. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddz163 · Cited by 27 · cited 2×
“These DAM or ARM cells are thought to regulate complement-dependent phagocytosis of synapses, which may be dependent on phospholipid signals presented on damaged cell membranes.(1,6,10,90,91) Emerging data also indicate that other subpopulations of microglia play a significant role in Alzheimer’s disease and ageing, p…”
BackgroundMethodSelf-citationCagliani, R., Fumagalli, M., Guerini, F. R., Riva, S., Galimberti, D., Comi, G. P., Agliardi, C., Scarpini, E. A., Pozzoli, U., Forni, D., et al. (2011) · Human Genetics · doi:10.1007/s00439-011-1053-2 · Cited by 24
de Klein, N., Tsai, E. A., Vochteloo, M., et al. (2021) · bioRxiv · doi:10.1101/2021.03.01.433439 · Cited by 23
The Intersection between COVID-19, the Gene Family of ACE2 and Alzheimer’s Disease
Haghighi, M. M., Kakhki, E. G., Sato, C., Ghani, M., & Rogaeva, E. A. (2020) · Neuroscience Insights · doi:10.1177/2633105520975743 · Cited by 20
Schmiedel, B. J., Chandra, V., Rocha, J., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.12.01.407429 · Cited by 15
Genetic variability in response to Aβ deposition influences Alzheimer’s risk
Salih, D. A., Bayram, S., Guelfi, M. S., Reynolds, R., Shoai, M., Ryten, M., Brenton, J., Zhang, D., Matarin, M., Botia, J., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/437657 · Cited by 12
Self-citationDvir-Szternfeld, R., Castellani, G., Arad, M., et al. (2020) · Research Square · doi:10.21203/rs.3.rs-113877/v1 · Cited by 2
Cited by
Zhang, J., Zhang, Y., Wang, J., Xia, Y., Zhang, J., & Chen, L. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01911-3 · Cited by 1,138
Mechanism and therapeutic potential of targeting cGAS-STING signaling in neurological disorders
Huang, Y., Liu, B., Sinha, S. C., Amin, S., & Gan, L. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00672-x · Cited by 164
“These enzymes possess architecture similarity to another NTase, 2 ′ 5 ′ -oligoadenylate synthase (OAS1) [95], which is a genetic risk factor for AD and severe COVID-19 outcomes [96], and produce diverse cyclic and oligonucleotides.”
BackgroundInborn errors of OAS–RNase L in SARS-CoV-2–related multisystem inflammatory syndrome in children
Lee, D., Le Pen, J., Yatim, A., Dong, B., Aquino, Y., Ogishi, M., Pescarmona, R., Talouarn, E., Rinchai, D., Zhang, P., et al. (2023) · Science · doi:10.1126/science.abo3627 · Cited by 158
“Nevertheless, genome-wide association studies have suggested that common variants in the vicinity of OAS1 may be weakly associated with COVID-19 severity ( 10 , 11 , 53 , 76 – 79 ).”
Kurki, S. N., Kantonen, J., Kaivola, K., Hokkanen, L., Mäyränpää, M. I., Puttonen, H., FinnGen, Martola, J., Pöyhönen, M., Kero, M., et al. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01302-7 · Cited by 91
Stadio, A. D., Brenner, M. J., Luca, P. D., Albanese, M., D’Ascanio, L., Ralli, M., Roccamatisi, D., Cingolani, C., Vitelli, F., Camaioni, A., et al. (2022) · Brain Sciences · doi:10.3390/brainsci12020154 · Cited by 80
“Because AD is more prevalent in women than men, [20] and SARS-CoV-2 inflammation can spread from the olfactory bulbs to other parts of the brain [21] increasing the neuroinflammation rate, we hypothize that anosmia may portend future neuro-degenerative neurological disease in predisposed subjects [18,22], as for examp…”
Background
Metadata
- Authors
- Magusali, N., Graham, A. C., Piers, T. M., Panichnantakul, P., Yaman, U., Shoai, M., Reynolds, R. H., Botia, J. A., Brookes, K. J., Guetta-Baranes, T., Bellou, E., Bayram, S., Sokolova, D., Ryten, M., Sala Frigerio, C., Escott-Price, V., Morgan, K., Pocock, J. M., Hardy, J., & Salih, D. A.
- Affiliations
- UK Dementia Research Institute (GB)
- UCL Queen Square Institute of Neurology (GB)
- UK Dementia Research Institute at UCL, Gower Street, London WC1E 6BT, UK
- UCL Biomedical Research Centre (GB)
- Department of Neurodegenerative Diseases, Queen Square Institute of Neurology, UCL, London WC1N 1PJ, UK
- Nottingham Trent University (GB)
- Genetics, School of Life Sciences, Life Sciences Building, University Park, University of Nottingham, Nottingham NG7 2RD, UK
- Cardiff University (GB)
- Hitachi Rail Europe Ltd, New Ludgate, London EC4M 7HX, UK
- Dementia Research Institute, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff CF24 4HQ, UK
- University of Nottingham (GB)
- Corresponding author
- Salih, Dervis A
- ORCID
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2021-10-07
- Volume
- 144
- Issue
- 12
- Pages
- 3727-3741
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- PMC
- PMC8500089
- OpenAlex
- W3201962999
- Cited by
- 111
- References
- 123
- Citations by year
- 2026: 6 · 2025: 18 · 2024: 20 · 2023: 25 · 2022: 41 · 2021: 1
- FWCI
- 13.98
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Brain (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- ORCA Online Research @Cardiff (Cardiff University) (acceptedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- Innovative Medicines Initiative 2 Joint Undertaking (115976)
- European Union's Horizon 2020
- European Federation of Pharmaceutical Industries and Associations
- Science and Technology Agency (00007/COVI/20)
- The University of Nottingham Group
- National Institute for Health Research University College London Hospitals Biomedical Research Centre
- Alzheimer’s Research UK
- UK Medical Research Council
- Alzheimer’s Society and ARUK
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Keywords
- Alzheimer's disease, COVID-19 pandemic, OAS1, genetic risk, microglia, interferon-stimulated genes, TNF-α, interferon-gamma, myeloid cells, inflammation, single nucleotide polymorphisms, induced pluripotent stem cell-derived microglia
- MeSH terms
- COVID-19, Adolescent, Aged, Aged, 80 and over, Alzheimer Disease, Cells, Cultured, Female, Humans, Genetic Linkage, Male, Middle Aged, 2',5'-Oligoadenylate Synthetase, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, Gene Regulatory Networks, Young Adult, Induced Pluripotent Stem Cells, Patient Acuity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.